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Abstract
Phosphotriesterases (PTEs) have been isolated from a range of bacterial species, including Agrobcaterium radiobacter (PTEAr),
and are efficient enzymes with broad substrate ranges. The turnover rate of PTEAr for the common organophosphorous
insecticide malathion is lower than expected based on its physical properties; principally the pka of its leaving group. In this
study, we rationalise the turnover rate of PTEAr for malathion using computational docking of the substrate into a high
resolution crystal structure of the enzyme, suggesting that malathion is too large for the PTEAr binding pocket. Protein
engineering through combinatorial active site saturation testing (CASTing) was then used to increase the rate of malathion
turnover. Variants from a CASTing library in which Ser308 and Tyr309 were mutated yielded variants with increased activity
towards malathion. The most active PTEAr variant carried Ser308Leu and Tyr309Ala substitutions, which resulted in a ca.
5000-fold increase in kcat/KM for malathion. X-ray crystal structures for the PTEAr Ser308Leu\Tyr309Ala variant demonstrate
that the access to the binding pocket was enhanced by the replacement of the bulky Tyr309 residue with the smaller
alanine residue.
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Introduction
The World Health Organization has estimated that there are .
3,000,000 cases of pesticide poisonings annually, which result in
approximately 200,000 deaths. Many of these cases are due to
accidental or deliberate intoxication with neurotoxic organophos-
phate pesticides (OPs) [1].
OPs are potent cholinesterase inhibitors used extensively for the
control of a variety of invertebrate pest species, but which also
effect acute intoxication in humans [2]. The OPs share a
phosphotriester structure, which is closely related to chemical
warfare agents, such as VX and Sarin (Fig. 1). Enzymes that
hydrolyse, and consequently detoxify, these phosphotriesters have
been isolated from diverse origins [3,4]. The best described of
these enzymes are the bacterial phosphotriesterases (PTEs).
PTEs have been isolated from a range of bacterial species,
including Pseudomonas diminuta (PTEPd) and Agrobacterium radiobacter
(PTEAr) [5,6]. They are binuclear metalloenzymes [7], highly
efficient catalysts and display broad substrate specificities that
include most phosphotriesters [5,6,8,9]. PTEs have therefore been
investigated for applications in environmental monitoring, pesti-
cide decontamination, nerve agent detoxification and in clinical
applications [9–15].
The SN2 mechanism of PTE, using a metal-activated water as
the nucleophile, is well documented [16–18]. This mechanism
results in a biphasic dependence of the rate of hydrolysis upon the
pKa of the leaving group of the substrate (Fig. 2). For OPs with
leaving groups that have pKa values of ,8.0 or lower the kcat/KM
for the reaction is near the diffusion limit, while at pKa values of
greater than ,8.0 there is a linear relationship between pKa and
log (kcat/KM). Outliers to this trend have been documented, with
their lower than expected turnover rates typically resulting from
physical barriers to correct substrate binding, such as steric
hindrance or non-productive binding [8,19,20].
The active site and substrate-binding pocket of the PTEs are
also well defined, with an iron-zinc binuclear metal center co-
ordinated by four histidine residues (His55, His57, His201 and
His230) and aspartate (Asp301) and an unusual carbamylated
lysine (Lys196), which bridges the center by co-coordinating both
metals [7] (numbering for PTEAr). The substrate-binding pocket is
comprised of a number of largely hydrophobic residues: Gly60,
Ser61, Ile106, Trp131, Phe132, Arg254, Tyr257, Leu271,
Leu303, Phe306, Ser308 and Phe309 in PTEAr [6,17–20]. The
large, hydrophobic substrate-binding pocket can accommodate the
majority of anthropogenic phosphotriesters [3,10,19], including
insecticides and nerve agents, and is responsible for the broad
substrate range of the enzyme.
PLOS ONE | www.plosone.org 1 April 2014 | Volume 9 | Issue 4 | e94177
The efficiency of PTE against many such substrates, including
chlorpyrifos, demeton-S, chlorfenvinphos, diisopropyl fluoroph-
sphate and others, has been improved by directed (laboratory)
evolution, rational design and incorporation of unnatural amino
acids [18,20–24]. However, there have been no reports of
substantial improvements in the turnover rate of PTEs towards
malathion, the most widely used OP insecticide in the US [25]
with significant applications in the control of West Nile virus and
fruit fly infestation [26,27].
Herein we have used Combinatorial Active-Site Saturation
Testing (CASTing) [28] to improve the efficiency of malathion
turnover by reducing the rate limitation caused by steric hindrance
of substrate binding.
Methods and Materials
Chemicals and reagents
All chemicals and reagents were obtained from Sigma-Aldrich.
Malathion and its metabolites were of analytical grade and .99%
pure. Synthetic oligonucleotides were obtained from GeneWorks
(Australia). Restriction enzymes were obtained from New England
Biolabs (Australia).
Bacterial growth
E. coli Bl21 (lDE3) was used for screening and production of
variant enzymes and was cultured in LB, on LB supplemented
with 1.5% w/v agar (LBA) or in Terrific Broth [29]. The media
were supplemented with 100 mg.mL21 ampicillin as required.
Figure 2. Brønsted plot of leaving group pKa values vs log(kcat/KM) for a range of substates. The pKa values of the leaving groups 2,6-
difluoro-4-nitrophenol; quinoxalin-2-ol; 2-fluoro-4-nitrophenol; 2-isopropyl-6-methylpyrimidin-4-ol; 3-fluoro-4-nitrophenol; 4-nitrophenol; 4-hydro-
xybenzaldehyde; 2,2-dichloroethylenol; 4-hydroxybenzonitrile; 1-(4-hydroxyphenol)ethanone; methyl 4-hydroxybenzoate; 4-hydroxybezamide; 3-
chloro-7-hydroxy-4-methyl-2H-chromen-2-one; 2-(ethylthio)ethanethiol; 2-(diethylamino)ethanethiol; 2-(diisopropylamino)ethanethiol; and 4-(meth-
oxymethyl)phenol plotted (left to right) against their log(kcat/KM) values. pKa values were as published elsewhere [8,17,20] or as calculated using the
SPARC online pKa calculator (http://ibmlc2.chem.uga.edu/sparc/) [38]. The biphasic dependence of the enzyme on pKa as described elsewhere [8,20]
is shown: the curve flattens below a pKa of ,8.0 and there is a linear dependence on pKa at values below ca. 8.0.
doi:10.1371/journal.pone.0094177.g002
Figure 1. Hydrolytic activity of PTEAr. A) Schematic showing the
PTEAr-mediated hydrolysis of malathion. B) Structure of the OP
insecticides demeton, chlorpyrifos, parathion and diazinon.
doi:10.1371/journal.pone.0094177.g001
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Site saturation libraries
pETMCS1-opdA was used as a template for the site saturation
mutagenesis libraries. The method of Ho et al. [30] was used to
make libraries of opdA mutants in which codons were replaced with
the NNS degenerate codon. Mutant libraries targeted either single
amino acid substitutions at position 106, 271 or 303 or two
simultaneous amino acid substitutions at positions 60 and 61, 131
and 132, 254 and 257, 306 and 308, and 308 and 309. Each of the
single substitution libraries encoded 32 variants and each of the
double substitution libraries encoded 1024 variants. The library
amplicons were cloned into pETMCSI [24] using NdeI and EcoRI.
The diversity of mutations within each library was ascertained by
sequencing plasmid DNA obtained from transformants prior to
any laboratory selection.
Screening for malathion hydrolase activity
For malathion hydrolase activity screening, competent BL21
(lDE3) were transformed with libraries cloned into pETMCS1,
plated on LBA and incubated at 37 uC overnight. Ninety five
transformants were screened from each library with single amino
acid substitutions and 3070 transformants screened from each
library with double amino acid substitutions; this resulted in each
library being screened at ,36 the diversity of the library.
Transformants were transferred into two 96-well growth blocks
(3 mL volume in each well), with each growth block containing 94
library transformants, one BL21 (lDE3) pETMCS1-OpdA colony
(base-line control) and one BL21 (lDE3) colony (negative control).
Growth blocks were incubated at 37 uC over night then
centrifuged at 5,3006g for 30 minutes to sediment the cultures.
The pellets were resuspended and lysed in 3 mL Bugbuster
solution (Novagen), according to the manufacturer’s instructions.
40 mL of cell-free extract (CFE) from each well was transferred to a
96-well microtitre plate.
The rate of malathion hydrolysis by the CFEs was followed by
measuring the rate of thiol group liberation (i.e. diethyl 2-
mercaptosuccinate formation) using Ellman’s reagent modified for
use in 96-well microtitre plate format: 140 ml of 5 mM Ellman’s
reagent containing 20 mM malathion was added to 40 ml of CFE.
The change in absorbance at 412 nm was measure for 30 min
using a SpectraMax M2 spectrophotometer (Molecular Devices,
CA).
Plasmids were obtained from transformants that possessed
greater malathion hydrolase activity than the BL21 (lDE3)
pETMCS1-OpdA control using a plasmid DNA purification kit
(Macherey-Nagel, Germany), and the sequences of the OpdA
mutants were obtained (Micromon, Melbourne).
Protein expression, purification and crystallization
PTEAr and variants were expressed in BL21 (lDE3) grown in
TB supplemented with 100 mM CoCl2 at 30 uC for 48 hours. The
cells were harvested after 48 hours by centrifugation (5,0006g for
15 min), pellets were then resuspended in 5 ml of 50 mM HEPES
with 1 mM CoCl2 (pH 8) per gram of cells. Cells were lysed using
an EmulsiflexC3 homogeniser (Avestin Inc., Germany) according
to the manufacturer’s instructions. Cell debris was removed by
centrifuging at 20,0006g for 30 minutes and the supernatant was
recovered.
PTEAr and variants were purified as described elsewhere
[17,19]. All columns and chromatographic media were purchased
from GE Healthcare. Protein concentration was determined using
a nanodrop ND-1000 spectrophotometer (Thermofisher Scientific,
Australia), assuming an extinction coefficient of 29,280 M21.cm21
[19]. Protein purity was monitored by using reducing pre-cast
SDS-PAGE gels (NuSep, Australia) stained with Coomasie
brilliant blue. PTEAr was crystallised as previously described
[7,18].
Crystal soaking and X-ray data collection
PTEAr crystals were serially transferred to cryoprotectant
solutions consisting of 40% PEG 3350 and 0.2 M NaNO3 with
or without 2 mM malathion for 2 minutes before data collection.
The crystals were flash-cooled to 100 K in a cryogenic nitrogen
gas stream. Diffraction data were collected on a Marresearch
marmX system, comprising a Xenocs Genix3D Cu high flux
generator and a mar345 image plate detector. All data reduction
was performed using XDS and CCP4 [31,32].
Structure determination
Crystals were isomorphous to those previously solved (space-
group P3121, a = 108.9, c = 62.4) [7,18]; accordingly, this model
was used to calculate the initial protein phases. REFMAC as
implemented in the CCP4 suite of program [33], was employed
for refinement. The structure and restrains for diethyl thiophos-
phate were taken from previous work [17]. Difference Fourier
maps obtained from soaked PTEAr crystals in the absence of bound
substrate/products were obtained initially, followed by inclusion of
the substrates/products in the models and real-space refinement
against the positive density using restraints and the COOT
Figure 3. Docking of malathion into the crystal structures of
wild-type PTEAR and PTEAR Ser308Leu/Tyr309Ala. A. The
substrate-binding pocket of PTEAr (2R1N) with bound substrate. The
amino acids that were randomised in this experiment are labelled. B.
Superimposed structures of malathion docked in the active site of PTEAr
in two different conformations. The branched leaving group of
malathion results in steric clashes with the protein, primarily with
Ser308 and Tyr309. C. Superimposed structures of malathion docked in
the active site of the minor, open, conformation of PTEAr in two
different conformations. The steric clash with Tyr309 is lessened. D.
Superimposed structures of malathion docked in the active site of the
Ser309Leu/Tyr309Ala variant of PTEAr. This shows that the Tyr309Ala
mutation has opened the substrate-binding cavity, removing the steric
hindrance to malathion binding in a productive conformation.
doi:10.1371/journal.pone.0094177.g003
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program [34]. These were further refined using REFMAC. Ligand
occupancy was adjusted until the B-factors of the ligands refined to
values comparable to the interacting metal ions/amino acids.
Enzyme assays
Rates of hydrolysis of malathion and demeton were measured
by quantifying the formation of thiol groups using the modified
Ellman’s assay [35], essentially as described above, 140 ml of
5 mM Ellman’s reagent containing malathion or demeton (0, 5,
10, 25, 50, 100, 150, 300, 400 and 600 mM) was added to 40 ml of
50 mM HEPES buffer containing 0.22–0.43 nM enzyme, as
appropriate. Each assay was conducted in triplicate. An extinction
co-efficient of 14,140 M21.cm21 [35] was used. Hydrolysis rates
for diazinon, chlorpyrifos and parathion were obtained spectro-
photometrically, as described elsewhere [10]. Rates were deter-
mined over 30 minutes. Values for kcat and KM were estimated
using ‘‘Hyper32’’ hyperbolic regression software [20].
Computational procedures
Docking of malathion to the PTEAr native structure with a water
molecule bridging the metal centres was performed using
CDOCKER as implemented in Accelrys Discovery Studio [36].
The top 10 poses were taken from a run docking 40 orientations of
40 conformers of malathion with simulated annealing for each
pose.
Results and Discussion
Malathion is a poor substrate for PTEAr
PTEAr has a kcat/KM value for malathion of 4610
2 s21.M21.
The pKa of the leaving group of malathion (diethyl 2-
mercaptosuccinate) is predicted to be 7.7, suggesting that
malathion is turned over by PTEAr with a kcat/KM that is at least
several order of magnitude lower than other phosphotriesters with
leaving groups that have similar pKa values (Fig. 2). This suggests
that another parameter, such as substrate binding or formation of
the Michaelis complex, may limit the rate of this reaction.
Figure 4. Screening for improved malathion hydrolase activity. The activity of three cell-free extracts from transformants isolated from the
Ser308Xxx/Tyr309Xxx libraries are shown alongside that of the cell-free extract from a transformant obtained using the unmodified gene. The library
transformants were subsequently shown to carry the Ser308Leu substitution and an Ala, Ser or Gly at 309. The data presented here are the averages
of three independent assays, replicates varied by less than 10%.
doi:10.1371/journal.pone.0094177.g004
Table 1. Kinetic parameters of purified PTEAr and most active variant against malathion for a range of OP insecticides.
Substrate Wild Type PTEAr Ser308Leu /Tyr309Ala
kcat(s
21) KM(mM) kcat/KM(s
21.M21) kcat(s
21) KM(mM) kcat/KM(s
21.M21)
Malathion 3.961022 1100 3.56101 7.66102 410 1.96106
(2.161023) (97) (3.36101) (35)
Parathion 6.26103 330 1.96107 9.16102 340 2.76106
(9.36101) (25) (8.26101) (31)
Demeton 1.461022 490 2.96101 1.161022 490 2.26101
(1.461023) (39) (9.361024) (17)
Diazinon 1.06103 480 2.16106 1.16103 430 2.56107
(9.66101) (46) (8.46101) (39)
Chlorpyrifos 3.86101 290 4.36105 2.36101 220 1.06106
(2.66100) (27) (2.16100) (13)
Standard deviations for the kcat and KM values are given in parentheses below the mean values obtained for triplicate experiments.
doi:10.1371/journal.pone.0094177.t001
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To rationalise the very low kinetic parameters of PTEAr with
malathion, we performed a series of computational docking
procedures using the CDOCKER algorithm. CDOCKER has
previously been verified crystallographically with PTEAr, produc-
ing a docked pose that was essentially superimposable with a
crystal structure of an PTEAr-diethyl 4-methoxyphenyl phosphate
complex [17](Fig. 3A). Forty orientations of forty conformers of
malathion were docked, with simulated annealing for each pose.
The results did not yield any poses that were productively bound
with the substrate appropriately aligned for nucleophilic attack
from the metal-ion coordinated nucleophile. To investigate
further, we superimposed various conformers of malathion onto
the substrate in a crystallographic PTEAr:substrate complex (Fig. 3).
This revealed that the substrate binding pocket was too small to
accommodate the branched leaving group of malathion, with
particular clashes near Ser308 and Tyr309 (Fig. 3B).
If malathion cannot bind to PTEAr, then how can the low, but
significant, turnover of this substrate be explained? Previous work
was shown that PTEAr fluctuates between open and closed
conformations [37], and that alternative open conformations
allowed the binding of another larger organophosphate, chlorfen-
vinfos [20]. When malathion is docked into this minor, open,
conformation, it is clear that the steric clashes no longer prevent
binding, i.e. a minor conformation appears to catalyze a non-
native activity (Fig. 3C). This low-level promiscuous activity
towards malathion, coupled with the relatively good leaving group
of this substrate, suggests that significant increases in activity
should be possible, provided the substrate binding site is
sufficiently modified to favour formation of the Michaelis complex.
CASTing for improved malathion hydrolysis
In accordance with the docking results, a semi-rational
approach was used to improve the turnover of this substrate.
CASTing was performed in the substrate-binding pocket of PTEAr,
with each of the residues that form the substrate-binding pocket
included in at least one CASTing library. CASTing is an approach
wherein analysis of an enzyme’s 3D structure is used to identify
groups of two or three amino acids from the binding-pocket, which
are then randomized simultaneously to create relatively small
libraries of mutants that can be screened with relatice ease. For
PTEAr, each CASTing library carried substitutions at one or two
amino acid positions and therefore producing libraries of 32 or
1024 variants (using an NNS degeneracy). The libraries were:
Gly60Xxx and Ser61Xxx, Ile106Xxx, Trp131Xxx and
Phe132Xxx, Arg254Xxx and Tyr257Xxx, Leu271Xxx,
Leu303Xxx, Phe306Xxx and Ser308Xxx, and Ser308Xxx and
Tyr309Xxx. Cell-free extract from each library was screened for
the rate of formation of free thiol (as a result of malathion
hydrolysis; Fig. 1), with 95 or 3070 transformants screened per
library depending upon the size of the library screened (i.e,
screened at ,36 the diversity of the library).
Table 2. Data collection and refinement statistics for structures reported in this work.
PTEAr Ser308Leu/Tyr309Ala PTEAr+2 mM malathion Ser308Leu/Tyr309Ala
Space group P3 12 1 P3 12 1
Unit-cell parameters
a (A˚) 57.09 109.10
b (A˚) 101.80 109.10
c (A˚) 79.89 63.43
a,b,c (6) 90, 90, 120 90, 90, 120
Data collection
Wavelength (A˚) 1.5418 1.5418
Resolution range (A˚)* 29.36–1.99 (2.04–1.99) 28.22–1.99 (2.04–1.99)
No. of unique reflections 29386 30260
Redundancy 10.8 (9.9) 7.2 (6.6)
Completeness (%) 99.8 (97.8) 99.8 (98.4)
Rmerge(I)
{ 0.122 (0.750) 0.123 (0.889)
Mean ,I/s(I). 20.2 (4.0) 15.4 (2.4)
CC1/2
¡ (0.998) (0.877) 0.997 (0.734)
Refinement
No. reflections (total) 27872 28317
Resolution range 29.36–1.99 (2.04–1.99) 28.22–1.99(2.04–1.99)
Rwork/Rfree
` 0.158/0.186 (0.212/0.278) 0.206/0.251 (0.266–0.319)
R.m.s deviations
Bond lengths (A˚) 0.022 0.019
Bond angles (u) 2.084 2.036
PDB ID 3WML 4NP7
*Values in parenthesis are for the highest-resolution shell.
{Rmerge(I) = (Shkl Sj |Ihkl,j2ÆIhklæ|)/(Shkl Sj Ihkl,j) where ÆIhklæ is the average intensity of j symmetry-related observations of reflections with Miller indices hkl.
#CC1/2 = percentage of correlation between intensities from random half-datasets.
`Rwork = Shkl|F(obs)2F(calc)|/Shkl|F(obs)|; 5% of the data that were excluded from the refinement were used to calculate Rfree.
doi:10.1371/journal.pone.0094177.t002
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Although the majority of transformants from all libraries
retained some hydrolytic activity against malathion, only the
library in which Ser308 and Tyr309 were targeted for mutagenesis
provided variants with increased activity towards malathion
compared with that of the wild-type enzyme (Fig 4). Variants
with increased rates of malathion activity were found to carry a
Ser308Leu substitution and a substitution of Tyr309 for Gly, Ser
or Ala. Site-directed mutants of wild-type opdA were constructed
that encoded only substitutions of Tyr309 for Gly, Ser or Ala;
however, the expressed variants were insoluble.
The steady-state kinetic parameters of the most active variant
(Ser308Leu, Tyr309Ala) were obtained and compared with those
of the wild-type enzyme. There was a 2.7-fold decrease in the KM
for malathion (410 vs. 1,100 mM; Table 1) and a 26104-fold
increase in kcat, (7.7610
2 vs. 3.961022 s21; Table 1), leading to a
5.46104-fold increase in the kcat/KM (1.9610
5 vs.
3.56101 s21.M21; Table 1). Thus, amino acid substitutions at
positions 308 and 309 alleviate the majority of the limitation on
the rate of malathion hydrolysis by PTEAr. Such large changes in
turnover rates were not observed with a range of other OP
insecticides including parathion (ca. 5-fold reduction in kcat/KM
value), ca. 2- and 9-fold increases in kcat/KM values for chlorpyrifos
and diazinon respectively, and no significant change in the rate of
demeton turnover (Table 1). These data suggest that the specific
interaction between PTEAr and malathion via amino acids at
positions 308 and 309 was responsible for the low turnover of
malathion by the wild-type enzyme.
Crystallographic analysis of PTEAr Ser308Leu/Tyr309Ala
In order to rationalise the effects of these mutations, we solved
the crystal structure of the PTEAr Ser308Leu/Tyr309Ala mutant
(crystallographic data in Table 2). This did not reveal any
significant changes to the backbone or B-factors of the loop that
these mutations are located on (Loop 7). However, the Tyr309Ala
mutation did expand the size of the active site entrance
substantially (Fig. 3D). To investigate whether the enzyme, as
constrained by the crystal packing, could still hydrolyze malathion,
we performed a crystal soaking experiment, in which we soaked
the crystal in 1 mM malathion for two minutes. The structural
model obtained from the soaked crystal revealed density in the
active site matching the product diethyl thiophosphate, in a known
product binding mode [17]. This establishes that the crystal
structure observed here is capable of hydrolysing malathion at
rapid rates.
To investigate whether this increase in activity was a result of
relieving the steric hindrance that was inhibiting substrate
turnover in the wild-type enzyme, we performed substrate docking
with malathion and the engineered Ser308Leu/Tyr309Ala variant
(Fig. 3D). These results confirmed that the widening of the active
site that occurs as a result of these mutations allows productive
substrate binding and vastly improved turnover rates. It also
explains the reduced turnover of paraoxon (Table 1): previous
work has established that the interaction between the aromatic
group of Tyr309 and the aromatic group of paraoxon, which is
lost in this mutant, enhances catalysis.
Summary
PTEAr has potential in a wide range of applications, due its high
turnover rates and broad substrate specificity. However, the
applicability of the wild-type enzyme is limited for some substrates,
such as malathion. Here we have enhanced the turnover rate for
malathion by ,5,000 fold using a semi-rational approach, which
has alleviated the steric hindrance responsible for the low rate of
malathion turn-over in the wild-type enzyme. The requirement for
two amino acid substitutions, adjacent to each other in the protein,
suggests that it would have been unlikely to have produced this
specific variant by another, purely random, method.
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